Literature DB >> 10663382

Cadmium in milk and mammary gland in rats and mice.

K Petersson Grawé1, A Oskarsson.   

Abstract

The purpose of the present investigation was to study the uptake of cadmium in mammary tissue, effects on milk secretion and composition, and lactational transport of cadmium to the sucklings. Cadmium exposure during lactation resulted in retention of cadmium in the mammary tissue in mice and rats. The uptake of cadmium in the mammary tissue was rapid, as shown in lactating mice by whole-body autoradiography 4 h after an intravenous injection of a tracer dose of (109)CdCl(2). Retention of cadmium in kidneys of suckling pups was observed in the autoradiograms at 7 days after exposure of the dams. Lactating rats were intravenously infused with (109)CdCl(2) in 0.9% saline via osmotic minipumps from day 3 to day 16 after parturition. The cadmium dose given was 0, 8.8, 62 and 300 microg Cd/kg body wt. per day. Plasma and milk were collected at day 10 and 16 after parturition. Plasma cadmium levels in dams increased from day 10 to day 16. Cadmium levels were higher in milk than in plasma, with milk/plasma ratios varying from 2 to 6. Zinc levels in milk were positively correlated to cadmium levels in milk (r(2)=0.26; P=0. 03). In milk, (109)Cd was distributed in fat (46-52%), casein fraction (40-46%), and whey fraction (6-8%). There was a high correlation between cadmium concentrations in pups' kidney and cadmium concentrations in dam's milk (r(2)=0.98; P < 0.001). Of the cadmium dose given to the dams <0.05% was retained in the litters on day 16 of lactation. No effects were observed due to cadmium exposure on body weight in pups or dams. Cadmium treatment did not cause any effect on the lactose or protein concentration in milk, the concentrations of DNA, RNA or the ratio RNA/DNA in the mammary gland. Histological evaluation of mammary tissue did not reveal any abnormalities at any dose level. (109)Cd was bound to metallothionein in mammary tissue. The fraction of radiolabelled cadmium bound to metallothionein increased in a dose-dependent manner in both the liver (88-98%) and mammary tissue (57-80%). The present results indicate a low transfer of cadmium to the suckling pup, which might be due to binding of cadmium to metallothionein in the mammary tissue. However, during the susceptible developmental period even a low cadmium exposure may be of concern.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10663382     DOI: 10.1007/s002040050003

Source DB:  PubMed          Journal:  Arch Toxicol        ISSN: 0340-5761            Impact factor:   5.153


  9 in total

Review 1.  Biological underpinnings of breastfeeding challenges: the role of genetics, diet, and environment on lactation physiology.

Authors:  Sooyeon Lee; Shannon L Kelleher
Journal:  Am J Physiol Endocrinol Metab       Date:  2016-06-28       Impact factor: 4.310

2.  Cadmium associated with inhaled cadmium oxide nanoparticles impacts fetal and neonatal development and growth.

Authors:  Jason L Blum; Judy Q Xiong; Carol Hoffman; Judith T Zelikoff
Journal:  Toxicol Sci       Date:  2012-01-12       Impact factor: 4.849

3.  Effects of Maternal Exposure to Cadmium Oxide Nanoparticles During Pregnancy on Maternal and Offspring Kidney Injury Markers Using a Murine Model.

Authors:  Jason L Blum; Joshua R Edwards; Walter C Prozialeck; Judy Q Xiong; Judith T Zelikoff
Journal:  J Toxicol Environ Health A       Date:  2015

Review 4.  Cadmium levels in Europe: implications for human health.

Authors:  Jilang Pan; Jane A Plant; Nikolaos Voulvoulis; Christopher J Oates; Christian Ihlenfeld
Journal:  Environ Geochem Health       Date:  2009-08-18       Impact factor: 4.609

5.  Cadmium-induced effects on bone in a population-based study of women.

Authors:  Agneta Akesson; Per Bjellerup; Thomas Lundh; Jonas Lidfeldt; Christina Nerbrand; Göran Samsioe; Staffan Skerfving; Marie Vahter
Journal:  Environ Health Perspect       Date:  2006-06       Impact factor: 9.031

Review 6.  Methods to identify and characterize developmental neurotoxicity for human health risk assessment. III: pharmacokinetic and pharmacodynamic considerations.

Authors:  D C Dorman; S L Allen; J Z Byczkowski; L Claudio; J E Fisher; J W Fisher; G J Harry; A A Li; S L Makris; S Padilla; L G Sultatos; B E Mileson
Journal:  Environ Health Perspect       Date:  2001-03       Impact factor: 9.031

Review 7.  Cadmium Handling, Toxicity and Molecular Targets Involved during Pregnancy: Lessons from Experimental Models.

Authors:  Tania Jacobo-Estrada; Mitzi Santoyo-Sánchez; Frank Thévenod; Olivier Barbier
Journal:  Int J Mol Sci       Date:  2017-07-22       Impact factor: 5.923

8.  Disruption of Bone Zinc Metabolism during Postnatal Development of Rats after Early Life Exposure to Cadmium.

Authors:  Sana Boughammoura; Safa Ben Mimouna; Marouen Chemek; Agnes Ostertag; Martine Cohen-Solal; Imed Messaoudi
Journal:  Int J Mol Sci       Date:  2020-02-12       Impact factor: 5.923

9.  Alteration of Mammary Gland Development and Gene Expression by In Utero Exposure to Cadmium.

Authors:  Daniela A Parodi; Morgan Greenfield; Claire Evans; Anna Chichura; Alexandra Alpaugh; James Williams; Kedra C Cyrus; Mary Beth Martin
Journal:  Int J Mol Sci       Date:  2017-09-09       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.